Jay T. Bishoff named regional director of urology at Northwell Health

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Jay T. Bishoff was named director of urology for Northwell Health’s Central Region, with oversight of urology sites in Nassau County and parts of eastern Queens. 

He also is a professor of urology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. His appointment is effective Aug. 2.

Based at Northwell’s The Smith Institute of Urology, with affiliations at North Shore University Hospital and Long Island Jewish Medical Center, Bishoff treats urological cancer patients using robotic and laparoscopic techniques. 

He is an expert in developing programs for quality improvement to increase better health outcomes. His areas of research and interest include cancer of the prostate, kidney, adrenal gland and testis.

Prior to joining Northwell, Bishoff was director of Intermountain Urological Institute at Intermountain Health Care in Salt Lake City, where he also held other clinical leadership positions over a 15-year span. 

Earlier, Bishoff was a U.S. Air Force surgeon, serving from 1998 to 2006, including during Operation Iraqi Freedom, treating patients at Balad, Iraq. He is also the author of Boots of War: Unforgettable Experiences from a Front Line Surgeon During Operation Iraqi Freedom.

Table of Contents

YOU MAY BE INTERESTED IN

Candace S. Johnson leads America’s oldest cancer research center and Jonathan W. Friedberg leads the newest NCI-designated center. Their catchment areas are contiguous, their faculty and staff members collaborate often, and together their institutions embody the culture of NCI-designated cancer centers. 

In the first meeting of the National Cancer Advisory Board since the inauguration of President Donald Trump, NCI Principal Deputy Director Douglas R. Lowy addressed many of the burning questions the oncology field has for the institute. On indirect costs: NCI will continue to use previously negotiated and approved indirect cost rates, with the exception...

The Cancer Letter staff were finalists for nine 2025 Dateline Awards from the Washington, D.C. Chapter of the Society of Professional Journalists—seven for journalism; two for design—and won first place for four. The Cancer Letter’s entries recognized by SPJ include investigative journalism, series, breaking news, features, photojournalism, commentary, illustration, and front page design. This is...

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login